In BC, PRMT1 can be triggered by radiotherapy, leading to the methylation of BRCA1, which facilitates its association with BARD1 and its location in the nucleus, so effectively beginning HR repair, blocking apoptosis, and increasing resistance to PARPis such as olaparib [102]. This evidence concerns the gene PRMT1 and breast cancer.